AKT1 and Alzheimer disease: As shown in Figure 8B, compared to the Con group, the ratio of p-AKT/AKT in the hippocampal tissues of mice in the AD group was significantly decreased (**p < 0.01), indicating that the activation of the AKT pathway was inhibited in the scopolamine-induced AD model.